
Serological markers associated with neuromyelitis optica spectrum disorders in South India
Author(s) -
Lekha Pandit,
Douglas Kazutoshi Sato,
Sharik Mustafa,
Toshiyuki Takahashi,
Anitha D’Cunha,
Chaithra Malli,
Akshatha Sudhir,
Kazuo Fujihara
Publication year - 2016
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.192389
Subject(s) - medicine , transverse myelitis , neuromyelitis optica , myelitis , serology , myelin oligodendrocyte glycoprotein , expanded disability status scale , population , antibody , pediatrics , multiple sclerosis , pathology , immunology , spinal cord , psychiatry , environmental health , experimental autoimmune encephalomyelitis
Neuromyelitis optica spectrum disorders (NMOSDs) represent 20% of all demyelinating disorders in South India. No studies have determined the seroprevalence to both antibodies against aquaporin-4* and antimyelin oligodendrocyte glycoprotein antibody (anti-MOG+) in this population.